PLYX
Polaryx TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
The constructive case is that the May financing bought enough time to reach SOTERIA initiation, and a clean trial launch could re-rate shares toward the May placement range because the platform value is currently being discounted for funding and execution risk. [#8-K-2026-05-28] [#10-K-2026-03-24]
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Clinical strategy is concentrated in an open-label, multi-indication basket study, which can create execution, recruitment, and interpretability risk before later registrational planning is clearer. [#10-K-2026-03-24]
Momentum
98
Value
46
Sentiment
44
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.10 · Bull $4.00 · Bear $1.00
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-11 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $8.50
Why
Momentum98 · Δ7d -
Value46 · Δ7d +0.0
Sentiment44 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
98
26% active weight
Current posture
7d trendSoftening
Δ7d
-
Δ21d
-
Value
46
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.0
Sentiment
44
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 98.3 / Value 46.4 / Sentiment 44.0
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$112.65M
Beta
-
Shares Out
49.85M
P/E (TTM) · Derived
-11.9
P/S (TTM)
-
P/FCF (TTM) · Derived
-20.18
Rev YoY
-
EPS YoY
-49.5%
Gross Margin
-
Op Margin
-
Net Debt
-$5.14M
Current Ratio
3.45
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology